Health Score

0 Fair

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 87 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact87 DOIs

Add license metadata to 73 records

License metadata tells indexers and readers how each article may be reused.

Medium impact73 DOIs

Deposit reference lists for 57 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact57 DOIs

DOIs for this ISSN

Showing the top 5 of 156 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Retrospective Evaluation of the Complications and Risk Facto… (10.4274/jpea.2025.394)	Abstract ORCID License	35.78	2
2	The Association Between Platelet Mass Index and Mechanical V… (10.51271/jpea-2021-0124)	ORCID License	23.86	2
3	Digital Media and Children (10.51271/jpea-2022-150)	References ORCID	23.86	2
4	Evaluation of Lupus Cases Related to TNF Inhibitors in Child… (10.4274/jpea.2022.226)	Abstract References ORCID	22.58	1
5	Effects of a School-Based Multicomponent Intervention on the… (10.4274/jpea.2025.361)	Abstract ORCID License	22.58	1
6	Pediatric Hyperprolactinemia: Clinical Features, Diagnostic… (10.4274/jpea.2025.389)	Abstract ORCID License	22.58	1
7	Evaluation of Psychiatric Consultations Requested from Pedia… (10.4274/jpea.2025.398)	Abstract ORCID License	22.58	1
8	Thyroid Autoantibody Positivity Based on Individual Complian… (10.4274/jpea.2025.456)	Abstract ORCID License	22.58	1
9	Does Dietary Treatment Cause Obesity in Phenylketonuria? Com… (10.51271/jpea-2021-0098)	References ORCID License	22.58	1
10	Valproic Acid-Induced Priapism in a Child (10.51271/jpea-2021-0109)	References ORCID License	22.58	1
11	Integrating Child Life Specialists in Pediatric Oncology and… (10.4274/jpea.2024.309)	References	19.45	5
12	Hereditary Red Blood Cell Enzymopathies (10.51271/jpea-2021-0120)	License	17.47	4
13	Do Vitamin D Levels Play a Role in Urinary Tract Infection i… (10.4274/jpea.2024.320)	References ORCID	15.05	1
14	Solitary Rectal Ulcer Syndrome in Children (10.51271/jpea-2021-0103)	References License	15.05	1
15	Evaluation of COVID-19 Patients Admitted to Pediatric Emerge… (10.51271/jpea-2021-128)	References License	15.05	1
16	Musculoskeletal Complaints: When Should We Consult a Pediatr… (10.51271/jpea-2022-152)	References ORCID	15.05	1
17	Evaluation of Etiological Causes in Children with Symptomati… (10.51271/jpea-2022-160)	References ORCID	15.05	1
18	Erciyes Clinical Guideline For Multisystem Inflammatory Synd… (10.51271/jpea-2022-182)	References	15.05	3
19	Prevalence of methotrexate intolerance in juvenile idiopathi… (10.51271/jpea-2022-184)	References ORCID	15.05	1
20	Resistant Chorea Successfully Treated with Intravenous Immun… (10.51271/jpea-2021-0146)	License	11.93	2
21	The importance of immature granulocyte and immature reticulo… (10.51271/jpea-2022-153)	References	11.93	2
22	Microbiologically Documented Infection-related Mortality in… (10.4274/jpea.2023.222)	ORCID	7.53	1
23	Unexpected Tumor Rupture in a Case of Treatment-naïve Neurob… (10.4274/jpea.2024.254)	ORCID	7.53	1
24	A Narrative Review: Transforming Pediatric Oncology Care Thr… (10.4274/jpea.2024.271)	ORCID	7.53	1
25	Assessment of Oxidative Stress and Plasma Gelsolin Levels in… (10.4274/jpea.2024.292)	References	7.53	1
26	Effective Use and Cost-Evaluation of Erythrocyte Suspension… (10.4274/jpea.2024.312)	ORCID	7.53	1
27	Hirschsprung Disease in a Female Infant: A Case Report (10.4274/jpea.2024.337)	References	7.53	1
28	Postinfectious Bronchiolitis Obliterans (10.51271/jpea-2021-0137)	License	7.53	1
29	A Patient Diagnosed with Li-Campeau Syndrome and Biotinidase… (10.4274/jpea.2022.221)	References ORCID	0.00	0
30	Analyse of Febrile Neutropenia Attacks in Children with Acut… (10.4274/jpea.2022.225)	References	0.00	0
31	Evaluation of Families’ Views on Disease Management by Apply… (10.4274/jpea.2022.228)	References ORCID	0.00	0
32	Breast Refusal and Maternal and Perinatal Risk Factors in th… (10.4274/jpea.2022.229)	References	0.00	0
33	Bloodstream Infections by Extendedspectrum β-lactamase-produ… (10.4274/jpea.2022.238)	References ORCID	0.00	0
34	Exfoliative Cheilitis in Childhood: A Successful Treatment w… (10.4274/jpea.2023.193)		0.00	0
35	The Relationship Between Dyspnea Severity with Radiological… (10.4274/jpea.2023.198)		0.00	1
36	Assessment of Hypertension in Children with Autosomal Domina… (10.4274/jpea.2023.199)		0.00	0
37	The Predictors of Pneumonia in Children with COVID-19 (10.4274/jpea.2023.200)		0.00	1
38	Case of Pediatric Urticaria Pigmentosa (10.4274/jpea.2023.201)		0.00	1
39	Is There a Relationship Between Vitamin D Level and Iron Def… (10.4274/jpea.2023.202)		0.00	2
40	Increase in Odontogenic Cervicofacial Infection Requiring Ho… (10.4274/jpea.2023.203)		0.00	1
41	Pneumococcal Meningitis with Serotype 7 Who Develops 12. Ner… (10.4274/jpea.2023.205)		0.00	0
42	Pragmatic Management of Hand Involvement in Extended Oligoar… (10.4274/jpea.2023.206)		0.00	0
43	Does the Use of Multiplex PCR Contribute to the Management o… (10.4274/jpea.2023.207)		0.00	0
44	Anxiety Levels of Children with Primary Ciliary Dyskinesia a… (10.4274/jpea.2023.208)		0.00	0
45	Evaluation of Leukemia and Solid Tumors in Refugee Children… (10.4274/jpea.2023.209)		0.00	7
46	Vitamin D, Insulin Resistance and Cytokine Levels in Obese P… (10.4274/jpea.2023.213)		0.00	0
47	Inherited Bone Marrow Failure Syndromes in Children (10.4274/jpea.2023.218)		0.00	3
48	A Patient Diagnosed with Li-Campeau Syndrome and Biotinidase… (10.4274/jpea.2023.221)		0.00	0
49	Analyse of Febrile Neutropenia Attacks in Children with Acut… (10.4274/jpea.2023.225)		0.00	1
50	Evaluation of Lupus Cases Related to TNF Inhibitors in Child… (10.4274/jpea.2023.226)		0.00	0